by R. Doyle Stulting, MD, PhD
R. Doyle Stulting, MD, PhD, talks about product labeling and physicians’ use of medications for off-label applications. This is a summary of the presentation that Dr. Stulting delivered at the first ACOS Summit. He is the director of the Stulting Research Center at the Woolfson Eye Institute in Atlanta.
1,173 video views and 27,488 series views since 10/18/2011
-
Refractive Predictability and Stability After Implantation of an Equiconvex…
-
Course on Phakic IOLs
-
Novel Technique for Stem Cell Therapy to the Subretinal Space
-
Course on Evaluation and Treatment of NTG
-
Epi-On Vs Epi-Off CXL for Keratoconus, Post-LASIK Ectasia
-
Small-Aperture Corneal Implants
-
Refractive Lens Exchange With Customized Bifocal Toric IOL
-
Corneal Topography and the Ectasia Risk Score System
-
Optimizing the Results of Presbyopic IOL Surgery
-
Laser Cataract Surgery Course
-
New Insights in the Molecular Genetics of Uveal Melanoma
-
Conventional Versus Laser Phacoemulsification on Dense Nuclear Cataracts
-
Laser Cataract Surgery: Will Patients Pay?
-
Update on 27-Gauge Surgery
-
Prostaglandin-Associated Periorbitopathy
-
Comparison of Effective Lens Position and Refractive Outcome: Femtosecond L…
-
The Future of US Physician Services
-
PCIOL Implantation With HumanOptics Iris Prosthesis
-
Clinical Results After Bilateral Implantation of Diffractive Multifocal IOL…
-
Same-Day Bilateral Intraocular Implant Surgery
-
Treatment of Recurrent Epithelial Ingrowth After LASIK
-
Off-Label Drug Use: How Does it Affect Me?
-
Upcoming Annual Meeting Highlights with Bill Trattler, MD
